Jacques Dumas, Chief Scientific Officer at TETRAPHASE PHARMACEUTICALS INC (TTPH), sold 7,155 shares at $5.86 ($42K) on 2017-08-17, disclosed to the SEC on 2017-08-21.
Scheduled sale ($42k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| TTPH | SELL | 2018-01-11 | $45K | — | Filing → |
| TTPH | SELL | 2017-11-02 | $106K | — | Filing → |
| TTPH | SELL | 2017-08-24 | $105K | — | Filing → |